GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Allianca Saude e Participacoes SA (BSP:AALR3) » Definitions » 5-Year EBITDA Growth Rate

Alliancaude e Participacoes (BSP:AALR3) 5-Year EBITDA Growth Rate : -22.20% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Alliancaude e Participacoes 5-Year EBITDA Growth Rate?

Alliancaude e Participacoes's EBITDA per Share for the three months ended in Dec. 2023 was R$-0.22.

During the past 12 months, Alliancaude e Participacoes's average EBITDA Per Share Growth Rate was 167.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -1.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -22.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alliancaude e Participacoes was 16.30% per year. The lowest was -47.20% per year. And the median was -0.10% per year.


Competitive Comparison of Alliancaude e Participacoes's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Alliancaude e Participacoes's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliancaude e Participacoes's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Alliancaude e Participacoes's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Alliancaude e Participacoes's 5-Year EBITDA Growth Rate falls into.



Alliancaude e Participacoes 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Alliancaude e Participacoes  (BSP:AALR3) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Alliancaude e Participacoes 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Alliancaude e Participacoes's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliancaude e Participacoes (BSP:AALR3) Business Description

Traded in Other Exchanges
N/A
Address
Rua Marselhesa, no. 500, 7th floor, Andar Vila Mariana, Sao Paulo, SP, BRA, 04020-060
Allianca Saude e Participacoes SA formerly Centro de Imagem Diagnosticos SA - Alliar is a diagnostic imaging company consisting of MRI machines, CT scanners and ultrasound machines. Its products include diagnostic medicine, diagnostic imaging and clinical analysis. The company is also engaged in the import of medical and hospital equipment, diagnosis kits, and related goods; Providing health consulting, advisory, courses and lectures.

Alliancaude e Participacoes (BSP:AALR3) Headlines

No Headlines